Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Javier Lizardi-Cervera"'
Autor:
Linda E. Munoz-Espinosa, Aldo Torre, Laura Cisneros, Iaarah Montalvo-Gordon, René Malé-Velázquez, Scherezada Mejía, Juan Ramón Aguilar-Ramírez, Javier Lizardi-Cervera, María E. Icaza-Chávez, Frida Gasca-Díaz, Larissa Hernández-Hernández, Paula Cordero-Perez, Luis A. Chi-Cervera, Lilian Torres-Made, Fátima Rodríguez-Álvarez, Graciela Tapia, Jorge Luis Poo
Publikováno v:
Annals of Hepatology, Vol 29, Iss , Pp 101472- (2024)
Introduction and Objectives: Advanced liver fibrosis (ALF) is a predictor of adverse prognosis in chronic liver disease. In addition to etiological treatment, a new approach to stop or reverse residual fibrosis would be desirable. Our aim was to asse
Externí odkaz:
https://doaj.org/article/e2f802b259ad4644b6abcff4efec9996
Autor:
Javier Lizardi-Cervera, Jorge Luis Poo, Karla Romero-Mora, Beatriz Castañeda, Raúl Pichardo-Bahena, Segundo Morán, Misael Uribe
Publikováno v:
Annals of Hepatology, Vol 5, Iss 4, Pp 257-262 (2006)
The role of hepatitis C virus (HCV) is well established in the development of chronic hepatitis, cirrhosis and hepatic carcinoma, as well as in mixed type II cryoglobulinemia, membranoproliferative glomerulonephritis (MPGN) and porphyria cutanea tard
Externí odkaz:
https://doaj.org/article/5f5edd07cac7453b9b6ce52977bd7be3
Publikováno v:
Annals of Hepatology, Vol 5, Iss 3, Pp 206-211 (2006)
Focal Nodular Hyperplasia (FNH) and Hepatic Adenoma (HA) are a benign tumors of the liver. The association with the use of oral contraception in women in middle age has been mentioned. This benign liver tumors are relatively rare lesions and are usua
Externí odkaz:
https://doaj.org/article/e3cf8610d93047f1aaf1d75fbad268ab
Publikováno v:
Annals of Hepatology, Vol 4, Iss 3, Pp 188-191 (2005)
Objective: To evaluate the frequency of hepatobiliary diseases and the clinical manifestations in patients with HIV treated with non highly active anti-retroviral therapy. Methods: Seven hundred clinical records of patients with HIV infection who ent
Externí odkaz:
https://doaj.org/article/4518be69d9a240739351a460110ba9b3
Publikováno v:
Annals of Hepatology, Vol 2, Iss 3, Pp 122-130 (2003)
Hepatic encephalopathy (HE) is a complication that presents in as many as 28% of patients with cirrhosis, and reported up to ten years after the diagnosis of cirrhosis. Commonly, it is observed in patients with severe hepatic failure and is character
Externí odkaz:
https://doaj.org/article/e86d1ff191b84f2daf1c2971b743e9fc
Publikováno v:
Annals of Hepatology, Vol 8, Iss , Pp S40-S43 (2009)
An association between non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) has been recently suggested. Indeed, different studies have demonstrated that NAFLD patients present increased subclinical atherosclerosis compared to n
Externí odkaz:
https://doaj.org/article/c462657ba70d416d93966ce2a551280e
Autor:
M.S. González-Huezo, J.A. Velarde-Ruiz Velasco, S.E. Martínez-Vázquez, A. Torre-Delgadillo, Gonzalo Torres-Villalobos, Nahum Méndez-Sánchez, Carlos A. Aguilar-Salinas, M. Castillo-Barradas, G.E. Castro-Narro, Diego Garcia-Compean, E. Márquez-Guillén, J.L. Poo-Ramírez, M.F. Higuera de la Tijera, Ignacio García-Juárez, M. Stoopen-Rometti, I. Aiza-Haddad, Norberto C. Chávez-Tapia, Juan Francisco Sánchez-Ávila, Ramón Carmona-Sánchez, Francisco Bosques-Padilla, Y. Gutiérrez-Grobe, J.A. Chávez-Barrera, L.E. Cisneros-Garza, Heriberto Rodríguez-Hernández, Javier Lizardi-Cervera, R. Trejo-Estrada, R. Moreno-Alcántar, M. Uribe-Esquivel, P. Ramos-Martínez, M.A. Ballesteros-Amozurrutia, D. Kershenobich-Stalnikowitz, R. Malé-Velázquez, J.A. López-Cossio, J. Flores-Calderón, L. Ladrón de Guevara-Cetina, R. Bernal-Reyes
Publikováno v:
Revista de Gastroenterología de México, Vol 84, Iss 1, Pp 69-99 (2019)
Resumen: La enfermedad por hígado graso no alcohólico (EHGNA) afecta prácticamente a un tercio de la población mundial. México es uno de los países cuya población reúne varios factores de riesgo para esta enfermedad y su prevalencia podría s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e3cd7acca921b6d968034cde742d10e
http://www.sciencedirect.com/science/article/pii/S0375090618301794
http://www.sciencedirect.com/science/article/pii/S0375090618301794
Autor:
A. Torre-Delgadillo, Francisco Bosques-Padilla, M.F. Higuera de la Tijera, Heriberto Rodríguez-Hernández, J.A. Chávez-Barrera, P. Ramos-Martínez, Y. Gutiérrez-Grobe, M.S. González-Huezo, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Stoopen-Rometti, J.L. Poo-Ramírez, S.E. Martínez-Vázquez, Ramón Carmona-Sánchez, D. Kershenobich-Stalnikowitz, G.E. Castro-Narro, J. Flores-Calderón, E. Márquez-Guillén, R. Bernal-Reyes, R. Malé-Velázquez, Juan Francisco Sánchez-Ávila, Norberto C. Chávez-Tapia, Ignacio García-Juárez, R. Trejo-Estrada, M.A. Ballesteros-Amozurrutia, Carlos A. Aguilar-Salinas, Diego Garcia-Compean, Javier Lizardi-Cervera, R. Moreno-Alcántar, I. Aiza-Haddad, M. Uribe-Esquivel, Nahum Méndez-Sánchez, J.A. Velarde-Ruiz Velasco, Gonzalo Torres-Villalobos, J.A. López-Cossio, L. Ladrón de Guevara-Cetina
Publikováno v:
Revista de Gastroenterología de México (English Edition), Vol 84, Iss 1, Pp 69-99 (2019)
Nonalcoholic fatty liver disease (NAFLD) affects nearly one third of the population worldwide. Mexico is one of the countries whose population has several risk factors for the disease and its prevalence could surpass 50%. If immediate action is not t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2c88fabaf786ff15b612d3606f61afd
https://doi.org/10.1016/j.rgmxen.2019.02.003
https://doi.org/10.1016/j.rgmxen.2019.02.003
Autor:
Martha H. Ramos, Oliver Perez-Bautista, Javier Lizardi-Cervera, Norberto C. Chávez-Tapia, Misael Uribe
Publikováno v:
Digestive Diseases and Sciences. 52:2375-2379
Nonalcoholic fatty liver disease (NAFLD) is associated with several metabolic disturbances involving inflammation. Ultrasensitive C-reactive protein (uCRP), a marker of coronary heart disease and other chronic diseases, has not been investigated in N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f67ab508174913b42daaf5d91ed9dcd2
https://doi.org/10.1007/s10620-006-9262-6
https://doi.org/10.1007/s10620-006-9262-6
Autor:
Beatriz Castañeda, Segundo Moran, Karla Romero-Mora, Raúl Pichardo-Bahena, J.L. Poo, Misael Uribe, Javier Lizardi-Cervera
Publikováno v:
Annals of Hepatology, Vol 5, Iss 4, Pp 257-262 (2006)
The role of hepatitis C virus (HCV) is well established in the development of chronic hepatitis, cirrhosis and hepatic carcinoma, as well as in mixed type II cryoglobulinemia, membranoproliferative glomerulonephritis (MPGN) and porphyria cutanea tard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c39171c753da2f5241874f06e6f00227
http://www.sciencedirect.com/science/article/pii/S1665268119319842
http://www.sciencedirect.com/science/article/pii/S1665268119319842